Phillip Mease

193PUBLICATIONS
306CO-AUTHORS
Toxicology (incl. clinical toxicology)Molecular targetsRheumatology and arthritisProsthetics and orthoticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (193)

|Aug 27, 2026
Efficacy and safety of upadacitinib in patients with psoriatic arthritis and exposure to one anti-TNF: post hoc analysis of SELECT-PsA 2.

|Jul 20, 2026
Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial.

|Jul 15, 2026
Psoriatic arthritis and obesity: a review of clinical burden and considerations for comprehensive care.

|Jun 29, 2026
Measurement properties of instruments assessing peripheral arthritis disease activity in spondyloarthritis: a systematic literature review.

|May 19, 2026
Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies.

|May 15, 2026
GRAPPA Research Projects: Development of Criteria for Axial Psoriatic Arthritis and Definitions of Complex-to-Manage and Treatment-Refractory Psoriatic Arthritis.

Pageof 33

Frequent Collaborators

40 joint publications

Laura C Coates

39 joint publications

Dafna Gladman

29 joint publications

Philip S Helliwell

23 joint publications

Oliver FitzGerald